Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239

Vered Daitch; Mical Paul; Leonard Leibovici

doi:10.3390/jcm11237029

Journal of Clinical Medicine (Nov 2022)

Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239

Vered Daitch,
Mical Paul,
Leonard Leibovici

Affiliations

Vered Daitch: Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 4941492, Israel
Mical Paul: Infectious Diseases Institute, Rambam Health Care Campus, Haifa 3109601, Israel
Leonard Leibovici: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel

DOI: https://doi.org/10.3390/jcm11237029
Journal volume & issue: Vol. 11, no. 23
p. 7029

Abstract

Read online

In the recently published meta-analysis titled “Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis”, Huang et al. compared the efficacy and safety of treatment with colistin monotherapy versus colistin plus meropenem combination therapy in patients with drug-resistant Acinetobacter baumannii infection [...]

n/a

Published in Journal of Clinical Medicine

ISSN: 2077-0383 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/jcm

About the journal

Abstract

Keywords